CKD screening at age 55, combined with SGLT2 inhibitors, reduces kidney failure incidence and improves life expectancy across racial and ethnic groups. Non-Hispanic Black adults experience the most ...
Yingye Zheng, Douglas A. Corley, Chyke Doubeni, Ethan Halm, Susan M. Shortreed, William E. Barlow, Ann Zauber, Tor Devin Tosteson, Jessica Chubak The Annals of ...